When is the best time for ovarian cancer surgery?
NCT ID NCT02828618
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the best time to perform surgery for advanced ovarian cancer. It compares having surgery right away versus after a few rounds of chemotherapy. The goal is to see which approach helps people live longer. About 800 women with stage IIIB-IV ovarian cancer are taking part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Klinik für Gynäkologie
Berlin, 13353, Germany
-
European Institute of Oncology; Gynecologic Cancer Surgery
Milan, Italy
-
Fondazione IRCCS Istituto Nazionale Tumori - Milan
Milan, Italy
-
Hôpital Européen Georges Pompidou (HEGP)
Paris, France
-
Imperial College London, Hammersmith Hospital, Surgery&Cancer
London, W12 OHS, United Kingdom
-
Institut Bergonié
Bordeaux, France
-
Institute Gustave Roussy
Villejuif, 94805, France
-
Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli
Naples, Italy
-
Kaiserswerther Diakonie; Florence-Nightingale-Hospital
Düsseldorf, Germany
-
Karolinska University Hospital
Solna, 17176, Sweden
-
Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München
München, 81377, Germany
-
Kliniken Essen-Mitte, Evang. Huyssens-Stiftung, Klinik für Gynäkologie und gyn. Onkologie
Essen, 45136, Germany
-
Klinikum rechts der Isar, Frauen- und Poliklinik
München, 81675, Germany
-
Medical University of Vienna
Vienna, A-1090, Austria
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Skane University Hospital
Lund, 22185, Sweden
-
University Hospital, Rigshospitalet
Copenhagen, 2100, Denmark
-
Universitätsklinikum Carl Gustav Carus Dresden, Klinik & Poliklinik f. Frauenheilkunde & Geburtshilfe
Dresden, 01307, Germany
-
Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Gynäkologie
Hamburg, 20246, Germany
-
Universitätsklinikum Tübingen
Tübingen, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Can a custom mRNA vaccine keep ovarian cancer from coming back?
- Can a cancer pill keep working outside the lab? a Real-World test begins
- Can a Patient's own immune cells be supercharged to fight ovarian cancer?
- Can a new drug ST316 shrink Hard-to-Treat tumors?